Cargando…
Interleukin-6 trans-signalling differentially regulates proliferation, migration, adhesion and maspin expression in human prostate cancer cells
Interleukin-6 (IL-6) is suggested to have a pathogenic role in the progression of prostate cancer (PC), therefore representing an attractive target for new therapies. However, due to the pleiotropy of this cytokine, targeting IL-6 results in different and unpredictable responses. In order to better...
Autores principales: | Santer, Frédéric R, Malinowska, Kamilla, Culig, Zoran, Cavarretta, Ilaria T |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Society for Endocrinology
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829126/ https://www.ncbi.nlm.nih.gov/pubmed/19966016 http://dx.doi.org/10.1677/ERC-09-0200 |
Ejemplares similares
-
Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways
por: Oh, Su Jung, et al.
Publicado: (2012) -
Interleukin‐4 induces a CD44(high)/CD49b(high) PC3 subpopulation with tumor‐initiating characteristics
por: Erb, Holger H.H., et al.
Publicado: (2018) -
Interleukin-6: A multifunctional targetable cytokine in human prostate cancer
por: Culig, Zoran, et al.
Publicado: (2012) -
Role of maspin in cancer
por: Berardi, Rossana, et al.
Publicado: (2013) -
Methylation-induced silencing of maspin contributes to the proliferation of human glioma cells
por: XU, LIANG, et al.
Publicado: (2016)